How Big Pharma is fighting Biden’s program to lower seniors’ drug costs
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
Drug companies have tried to invalidate a program that would reduce the price of medications for high blood pressure, heart disease, cancer and diabetes.
The goal of the report is to increase public understanding of cancer health disparities and of the importance of research on disparities to save lives.
The goal of the report is to increase public understanding of cancer health disparities and of the importance of research on disparities to save lives.
Individuals with higher blood levels of omega-3 and omega-6 fatty acids, especially omega-3, are less likely to die, either from any cause, cancer or cardiovascular…
One of the major determinants of exercise intolerance and limiting symptoms among patients with obstructive hypertrophic cardiomyopathy (HCM) is an elevated intracardiac pressure resulting from…
AbstractAdagrasib, an irreversible, selective KRASG12C inhibitor, may be an effective treatment in KRASG12C-mutated colorectal cancer, particularly when combined with an anti-EGFR antibody. In this analysis…
In some parts of England, there are proposals to divide NHS primary care services. NHS England’s strategy aims to separate patients with “same-day” acute care…
The OncoAlert Newsletter is now out for June 23-29, 2023
Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 450+ Peer Reviewed papers,…
In February, ASCO named molecular profiling driving progress in gastrointestinal cancers as its “Advance of the Year.” According to the American Cancer Society, taken collectively,…
Background Adoptive cell therapy, such as chimeric antigen receptor (CAR)-T cell therapy, has improved patient outcomes for hematological malignancies. Currently, four of the six FDA-approved…